Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 445

1.

Accuracy of online health information on amblyopia and strabismus.

Park S, Moskowitz C, Moon JY, Geddie B, Walsh E, Rosenberg JB.

J AAPOS. 2019 Oct 11. pii: S1091-8531(19)30503-8. doi: 10.1016/j.jaapos.2019.09.007. [Epub ahead of print] No abstract available.

PMID:
31610240
2.

Mechanical effects of MitraClip on leaflet stress and myocardial strain in functional mitral regurgitation - A finite element modeling study.

Zhang Y, Wang VY, Morgan AE, Kim J, Handschumacher MD, Moskowitz CS, Levine RA, Ge L, Guccione JM, Weinsaft JW, Ratcliffe MB.

PLoS One. 2019 Oct 10;14(10):e0223472. doi: 10.1371/journal.pone.0223472. eCollection 2019.

3.

Performance of Dual-Energy Contrast-enhanced Digital Mammography for Screening Women at Increased Risk of Breast Cancer.

Sung JS, Lebron L, Keating D, D'Alessio D, Comstock CE, Lee CH, Pike MC, Ayhan M, Moskowitz CS, Morris EA, Jochelson MS.

Radiology. 2019 Oct;293(1):81-88. doi: 10.1148/radiol.2019182660. Epub 2019 Aug 27.

PMID:
31453765
4.

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.

Chen R, Zinzani PL, Lee HJ, Armand P, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Lin J, Kim E, Nahar A, Balakumaran A, Moskowitz CH.

Blood. 2019 Oct 3;134(14):1144-1153. doi: 10.1182/blood.2019000324. Epub 2019 Aug 13.

PMID:
31409671
5.

Five-Year Follow-up of SWOG S0816: Limitations and Values of a PET-Adapted Approach for Stage III/IV Hodgkin Lymphoma.

Stephens DM, Li H, Schöder H, Straus DJ, Moskowitz CH, Leblanc M, Rimsza LM, Bartlett NL, Evens AM, LaCasce AS, Barr PM, Knopp MV, Hsi E, Leonard JP, Kahl B, Smith SM, Friedberg JW.

Blood. 2019 Jul 22. pii: blood.2019000719. doi: 10.1182/blood.2019000719. [Epub ahead of print]

PMID:
31331918
6.

Radiation Dose and Volume to the Pancreas and Subsequent Risk of Diabetes Mellitus.

Friedman DN, Moskowitz CS, Hilden P, Howell RM, Weathers RE, Smith SA, Wolden SL, Tonorezos ES, Mostoufi-Moab S, Chow EJ, Meacham LR, Chou JF, Whitton JA, Leisenring WM, Robison LL, Armstrong GT, Oeffinger KC, Sklar CA.

J Natl Cancer Inst. 2019 Jul 22. pii: djz152. doi: 10.1093/jnci/djz152. [Epub ahead of print]

PMID:
31329225
7.

Immune-checkpoint inhibition as first-line therapy for Hodgkin lymphoma.

Alencar AJ, Moskowitz CH.

Nat Rev Clin Oncol. 2019 Oct;16(10):599-600. doi: 10.1038/s41571-019-0255-8. No abstract available.

PMID:
31308512
8.

CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma.

Sauter CS, Senechal B, Rivière I, Ni A, Bernal Y, Wang X, Purdon T, Hall M, Singh AN, Szenes VZ, Yoo S, Dogan A, Wang Y, Moskowitz CH, Giralt S, Matasar MJ, Perales MA, Curran KJ, Park J, Sadelain M, Brentjens RJ.

Blood. 2019 Aug 15;134(7):626-635. doi: 10.1182/blood.2018883421. Epub 2019 Jul 1.

PMID:
31262783
9.

Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.

Moskowitz CS, Chou JF, Neglia JP, Partridge AH, Howell RM, Diller LR, Novetsky Friedman D, Barnea D, Morton LM, Turcotte LM, Arnold MA, Leisenring WM, Armstrong GT, Robison LL, Oeffinger KC, Henderson TO.

J Clin Oncol. 2019 Aug 20;37(24):2120-2130. doi: 10.1200/JCO.18.02219. Epub 2019 Jul 1.

PMID:
31260644
10.

Promoting Breast Cancer Surveillance: The EMPOWER Study, a Randomized Clinical Trial in the Childhood Cancer Survivor Study.

Oeffinger KC, Ford JS, Moskowitz CS, Chou JF, Henderson TO, Hudson MM, Diller L, McDonald A, Ford J, Mubdi NZ, Rinehart D, Vukadinovich C, Gibson TM, Anderson N, Elkin EB, Garrett K, Rebull M, Leisenring W, Robison LL, Armstrong GT.

J Clin Oncol. 2019 Aug 20;37(24):2131-2140. doi: 10.1200/JCO.19.00547. Epub 2019 Jul 1.

PMID:
31260642
11.

Automated Breast Density Measurements From Chest Computed Tomography Scans.

Qureshi TA, Veeraraghavan H, Sung JS, Kaplan JB, Flynn J, Tonorezos ES, Wolden SL, Morris EA, Oeffinger KC, Pike MC, Moskowitz CS.

J Med Syst. 2019 Jun 22;43(8):242. doi: 10.1007/s10916-019-1363-9.

PMID:
31230138
12.

Clinical significance of perifissural nodules in the oncologic population.

Golia Pernicka JS, Hayes SA, Schor-Bardach R, Sharma R, Zheng J, Moskowitz C, Ginsberg MS.

Clin Imaging. 2019 Sep - Oct;57:110-114. doi: 10.1016/j.clinimag.2019.05.017. Epub 2019 May 31.

PMID:
31207563
13.

Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse.

Kumar A, Sha F, Toure A, Dogan A, Ni A, Batlevi CL, Palomba MLM, Portlock C, Straus DJ, Noy A, Horwitz SM, Moskowitz A, Hamlin P, Moskowitz CH, Matasar MJ, Zelenetz AD, Younes A.

Blood Cancer J. 2019 May 20;9(6):50. doi: 10.1038/s41408-019-0209-5.

14.

Late Gadolinium Enhancement Cardiac Magnetic Resonance Tissue Characterization for Cancer-Associated Cardiac Masses: Metabolic and Prognostic Manifestations in Relation to Whole-Body Positron Emission Tomography.

Chan AT, Fox J, Perez Johnston R, Kim J, Brouwer LR, Grizzard J, Kim RJ, Matasar M, Shia J, Moskowitz CS, Steingart R, Weinsaft JW.

J Am Heart Assoc. 2019 May 21;8(10):e011709. doi: 10.1161/JAHA.118.011709.

15.

Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma.

von Tresckow B, Fanale M, Ardeshna KM, Chen R, Meissner J, Morschhauser F, Moskowitz C, Zinzani PL, Giezek H, Balakumaran A, Vo TT, Raut M, Brice P.

Leuk Lymphoma. 2019 Apr 23:1-7. doi: 10.1080/10428194.2019.1602262. [Epub ahead of print]

PMID:
31012356
16.

Clinical presentation determines selection of patients for initial observation in mantle cell lymphoma.

Kumar A, Ying Z, Alperovich A, Dogan A, Hamlin P, Moskowitz C, Pichardo J, Portlock C, Sha F, Zelenetz AD, Zhang Z, Drill E, Woo K, Younes A.

Haematologica. 2019 Apr;104(4):e163-e166. doi: 10.3324/haematol.2018.201350. No abstract available.

17.

Novel agents may positively impact chemotherapy and transplantation in subsets of diffuse large B-cell lymphoma.

Dahi PB, Moskowitz CH, Giralt SA, Lazarus HM.

Expert Rev Hematol. 2019 Jun;12(6):407-418. doi: 10.1080/17474086.2019.1596793. Epub 2019 May 17.

PMID:
30884247
18.

Novel agents positively impact chemotherapy and transplantation in Hodgkin lymphoma.

Dahi PB, Moskowitz CH, Giralt SA, Lazarus HM.

Expert Rev Hematol. 2019 Apr;12(4):255-264. doi: 10.1080/17474086.2019.1593135. Epub 2019 Mar 21.

PMID:
30874456
19.

Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation.

Alderuccio JP, Zhao W, Desai A, Ramdial J, Gallastegui N, Kimble E, de la Fuente MI, Husnain M, Rosenblatt JD, Alencar AJ, Schatz JH, Moskowitz CH, Chapman JR, Vega F, Reis IM, Lossos IS.

Am J Hematol. 2019 May;94(5):585-596. doi: 10.1002/ajh.25446. Epub 2019 Mar 10.

PMID:
30784098
20.

Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma.

Borchmann S, Joffe E, Moskowitz CH, Zelenetz AD, Noy A, Portlock CS, Gerecitano JF, Batlevi CL, Caron PC, Drullinsky P, Hamilton A, Hamlin PA Jr, Horwitz SM, Kumar A, Matasar MJ, Moskowitz AJ, Owens CN, Palomba ML, Younes A, Straus DJ.

Blood. 2019 May 16;133(20):2121-2129. doi: 10.1182/blood-2018-10-877761. Epub 2019 Feb 15.

PMID:
30770396

Supplemental Content

Loading ...
Support Center